Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 200-205, January 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarkson, J. M.
Right arrow Articles by Humphrey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarkson, J. M.
Right arrow Articles by Humphrey, R. M.

The Effect of Adriamycin on Cell Cycle Progression and DNA Replication in Chinese Hamster Ovary Cells1

Judith M. Clarkson and Ronald M. Humphrey

Department of Physics, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030

Chinese hamster ovary cells were treated with adriamycin (ADR) at various stages of the cell cycle in order to determine the effect on cell cycle progression and subsequent DNA replication. Concentrations of ADR up to 5 µg/ml for 15 min produced no progression delay in cells treated 1 hr prior to mitosis, and concentrations of 2 µg/ml or lower had no effect on the progression to mitosis of G2 or late S-phase cells. However, cells treated in mid-S phase showed a significant, dose-dependent delay at concentrations as low as 0.5 µg/ml. This cell cycle effect on progression was also reflected in the rates of DNA replication in the subsequent S phase. DNA replication was not inhibited by 5 µg/ml for 30 min when applied in either the G1, M, or G2 phase. In contrast, when ADR was applied in the S or G1 phases of the previous cell cycle, a marked depression in the rate of replication of DNA was observed. This was found to be the case for DNA synthesized both before and after the ADR treatment.

1 This work was supported in part by National Cancer Institute Grant CA-04484 and Contract N01 CN 61156.

Received 3/12/76. Accepted 10/12/76.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.